1. Home
  2. AIRG vs BRNS Comparison

AIRG vs BRNS Comparison

Compare AIRG & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airgain Inc.

AIRG

Airgain Inc.

HOLD

Current Price

$4.70

Market Cap

47.4M

Sector

Technology

ML Signal

HOLD

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

HOLD

Current Price

$0.73

Market Cap

55.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRG
BRNS
Founded
1995
2016
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.4M
55.9M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
AIRG
BRNS
Price
$4.70
$0.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$6.25
$4.00
AVG Volume (30 Days)
54.5K
37.6K
Earning Date
02-26-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1766.46
52 Week Low
$3.00
$0.64
52 Week High
$7.40
$2.92

Technical Indicators

Market Signals
Indicator
AIRG
BRNS
Relative Strength Index (RSI) 64.30 41.59
Support Level $4.12 $0.70
Resistance Level $4.66 $0.75
Average True Range (ATR) 0.27 0.03
MACD 0.03 0.00
Stochastic Oscillator 82.22 0.00

Price Performance

Historical Comparison
AIRG
BRNS

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Share on Social Networks: